Fortem Financial Group LLC Grows Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Fortem Financial Group LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 818 shares of the healthcare conglomerate’s stock after acquiring an additional 117 shares during the quarter. Fortem Financial Group LLC’s holdings in UnitedHealth Group were worth $414,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of UNH. Delta Financial Group Inc. increased its position in shares of UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after acquiring an additional 17 shares in the last quarter. Fiduciary Group LLC boosted its position in shares of UnitedHealth Group by 0.5% during the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after buying an additional 18 shares during the last quarter. First PREMIER Bank raised its position in UnitedHealth Group by 7.0% in the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock worth $160,000 after buying an additional 18 shares during the last quarter. Genesee Capital Advisors LLC grew its stake in shares of UnitedHealth Group by 1.9% in the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock worth $579,000 after acquiring an additional 18 shares during the period. Finally, Jmac Enterprises LLC lifted its position in UnitedHealth Group by 2.2% during the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after purchasing an additional 18 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $2.40 on Monday, reaching $510.60. The company’s stock had a trading volume of 2,718,461 shares, compared to its average volume of 3,281,867. The company has a 50-day simple moving average of $559.83 and a 200 day simple moving average of $561.31. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market cap of $469.90 billion, a P/E ratio of 33.26, a PEG ratio of 1.53 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the prior year, the firm posted $6.56 earnings per share. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Analyst Ratings Changes

A number of research firms recently commented on UNH. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, December 9th. UBS Group cut their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. KeyCorp assumed coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target for the company. Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Finally, Morgan Stanley lowered their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $627.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.